2009
DOI: 10.1016/j.cct.2009.03.001
|View full text |Cite
|
Sign up to set email alerts
|

A multisite trial of mifepristone for the treatment of psychotic depression: A site-by-treatment interaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 53 publications
(28 citation statements)
references
References 15 publications
0
28
0
Order By: Relevance
“…In modern literature, black bile has been replaced by cortisol of which the brain effects are studied by a myriad of researchers throughout the world. However, the therapeutic efficacy of inhibitors of cortisol synthesis or antagonists of glucocorticoid receptor activity has not yet fulfilled its premises in psychiatry (Blasey et al 2009; Kling et al 2009) and the pathogenesis of depression still remains elusive.…”
Section: Inflammation-associated Depression – Human Studiesmentioning
confidence: 99%
“…In modern literature, black bile has been replaced by cortisol of which the brain effects are studied by a myriad of researchers throughout the world. However, the therapeutic efficacy of inhibitors of cortisol synthesis or antagonists of glucocorticoid receptor activity has not yet fulfilled its premises in psychiatry (Blasey et al 2009; Kling et al 2009) and the pathogenesis of depression still remains elusive.…”
Section: Inflammation-associated Depression – Human Studiesmentioning
confidence: 99%
“…Also, many individuals with depression have elevated 24-h corticosteroid levels and escape dexamethasone-induced suppression of the HPA axis; normalization of these parameters generally precedes the relief of depressive symptoms, and the degree of HPA-axis normalization in turn predicts the relapse probability. Finally, anti-glucocorticoids given (as adjunct to antidepressants) to patients with psychotic depression accelerate and increase chances on successful treatment (DeBattista and Belanoff, 2006), provided that the anti-glucocorticoids levels are very high (Blasey et al, 2009). …”
Section: Introductionmentioning
confidence: 99%
“…Psychotic major depression was not significantly affected by antiglucocorticoid treatment. Although a study with mifepristone using plasma concentrations to assess drug exposure have been positive (Blasey et al, 2009), several studies with CRH R1 receptor antagonists as monotherapy have failed (Holtzheimer and Nemeroff, 2008).…”
Section: Monotherapy Targets Of the Hypothalamic Pituitary Axismentioning
confidence: 99%